Quarterly report [Sections 13 or 15(d)]

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)

v3.26.1
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 25, 2025
USD ($)
Sep. 24, 2025
USD ($)
Mar. 31, 2026
USD ($)
item
Dec. 31, 2025
USD ($)
Jan. 15, 2026
USD ($)
Aug. 31, 2025
shares
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Number of approved prescription drugs for dermatological conditions | item     8      
Cash and cash equivalents     $ 27,219 $ 24,090    
Working capital     $ 27,100 29,400    
Maximum number of shares available for sale | shares           3,750,000
Maximum authorized share capital amount         $ 150,000  
Third Amendment | SWK Funding LLC | Term loan            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Minimum amount of revenue $ 60,000 $ 70,000   $ 60,000